Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drug development research

Showing results (171-180 of 1,372) with videos related to

Pageof 138
Sort By:
Drug Development Research|May 27, 2026
Lead Discovery via Scaffold Refinement: Structure-Guided Optimization of 1,2,4-Triazolo[1,5-a]Pyrimidines as Potent Dual EGFR/CDK-2 Inhibitors Targeting Colorectal CarcinomaRowida Nasr, Hesham Haffez, Mohamed S Nafie, et al.
Drug Development Research|June 9, 2026
Entacapone Ameliorates MASLD by Inhibiting FTO Demethylase ActivitySunita Giri, Deepti Sharma, Vijay Kumar
Drug Development Research|April 10, 2026
Targeting the NLRP3 Inflammasome: Novel Inhibitors for Cardiovascular Diseases Management - A Narrative ReviewYomna S Momen
Drug Development Research|March 30, 2026
Design and Synthesis of Bis-3,4-Dimethoxybenzene-Fibrate Derivatives as Potential Lipid-Lowering and Hepatoprotective Agents Based on the Principles of Structural Simplification and BioisosterismLing Ding, Yuyu An, Huizi Shangguan, et al.
Drug Development Research|April 1, 2026
Unlocking the Anticancer Potential of New Spirooxindoles via p53-MDM2/MDMX Dual Inhibition: In Vitro and In Silico AssessmentsHaidy H El-Zoheiry, Rehab F Ahmed, Mahmoud S Elkotamy, et al.
Drug Development Research|April 27, 2026
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone LossHongming Zhou, Xiaoxi Liu, Hengren Li, et al.
Drug Development Research|May 12, 2026
Pyrimidine-Derived Scaffolds Targeting VEGFR-2, EGFR, and HER-2: Synthesis, Anticancer/Immunomodulatory Evaluation, and In Silico AnalysisNaglaa M Ahmed, Mohamed S Gaballah, Belen Altava, et al.
Drug Development Research|May 11, 2026
Exploring the Role of Novel N (4) Substituted 5,7-Dibromoisatin Thiosemicarbazones in Modulating PTOV1 Activity for Therapeutic Relevance in Breast CancerPiyush Kumar, Upendra Chaudhary, Kuldeep Mahiya, et al.
Drug Development Research|April 20, 2026
PKCδ-Drp1 Axis Mediates VIP-Induced Mitochondrial Fragmentation and Metabolic Crisis in Nasopharyngeal CarcinomaJingda Xu, Guanzheng Wu, Min Chen, et al.
Drug Development Research|April 27, 2026
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling PathwayYuanyuan Zhong, Yang Zou, Zhen Qu, et al.
Pageof 138

Showing results (171-180 of 1,372) with videos related to

Sort By:
Pageof 138
Drug Development Research|May 27, 2026
Lead Discovery via Scaffold Refinement: Structure-Guided Optimization of 1,2,4-Triazolo[1,5-a]Pyrimidines as Potent Dual EGFR/CDK-2 Inhibitors Targeting Colorectal CarcinomaRowida Nasr, Hesham Haffez, Mohamed S Nafie, et al.
Drug Development Research|June 9, 2026
Entacapone Ameliorates MASLD by Inhibiting FTO Demethylase ActivitySunita Giri, Deepti Sharma, Vijay Kumar
Drug Development Research|April 10, 2026
Targeting the NLRP3 Inflammasome: Novel Inhibitors for Cardiovascular Diseases Management - A Narrative ReviewYomna S Momen
Drug Development Research|March 30, 2026
Design and Synthesis of Bis-3,4-Dimethoxybenzene-Fibrate Derivatives as Potential Lipid-Lowering and Hepatoprotective Agents Based on the Principles of Structural Simplification and BioisosterismLing Ding, Yuyu An, Huizi Shangguan, et al.
Drug Development Research|April 1, 2026
Unlocking the Anticancer Potential of New Spirooxindoles via p53-MDM2/MDMX Dual Inhibition: In Vitro and In Silico AssessmentsHaidy H El-Zoheiry, Rehab F Ahmed, Mahmoud S Elkotamy, et al.
Drug Development Research|April 27, 2026
DPP4-Driven Ferroptosis Promotes Senescence: Galangin as a Therapeutic Agent for Age-Related Bone LossHongming Zhou, Xiaoxi Liu, Hengren Li, et al.
Drug Development Research|May 12, 2026
Pyrimidine-Derived Scaffolds Targeting VEGFR-2, EGFR, and HER-2: Synthesis, Anticancer/Immunomodulatory Evaluation, and In Silico AnalysisNaglaa M Ahmed, Mohamed S Gaballah, Belen Altava, et al.
Drug Development Research|May 11, 2026
Exploring the Role of Novel N (4) Substituted 5,7-Dibromoisatin Thiosemicarbazones in Modulating PTOV1 Activity for Therapeutic Relevance in Breast CancerPiyush Kumar, Upendra Chaudhary, Kuldeep Mahiya, et al.
Drug Development Research|April 20, 2026
PKCδ-Drp1 Axis Mediates VIP-Induced Mitochondrial Fragmentation and Metabolic Crisis in Nasopharyngeal CarcinomaJingda Xu, Guanzheng Wu, Min Chen, et al.
Drug Development Research|April 27, 2026
Secoisolariciresinol Diglucoside Alleviates LPS-Induced Acute Lung Injury by Inhibiting the NF-κB/NLRP3 Signaling PathwayYuanyuan Zhong, Yang Zou, Zhen Qu, et al.
Pageof 138